Form 4: RxSight COO Exercises Stock Options, Boosts Holdings
Insider Transaction Report
RxSight's Co-President and COO, Ilya Goldshleger, exercised a significant number of stock options, acquiring common stock and increasing his direct beneficial ownership.
Summary
- Ilya Goldshleger, Co-President and Chief Operating Officer of RxSight, Inc., reported transactions on September 25, 2025.
- Exercised stock options to acquire 15,096 shares of common stock at an exercise price of $4.34 per share.
- Exercised additional stock options to acquire 8,349 shares of common stock at an exercise price of $4.13 per share.
- Following these transactions, Goldshleger directly beneficially owns 65,691 shares of common stock.
- An additional 1,372 shares are indirectly beneficially owned by his spouse.
- The exercise of options resulted in 5,416 and 9,680 options being fully exercised, with 0 remaining for those specific grants.
- For another grant, 8,349 options were exercised, leaving 12,494 options remaining.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive. An executive exercising stock options to increase direct ownership generally indicates confidence in the company's future performance and value, although it is not a fresh open-market purchase.
Positives
- The exercise of stock options by a high-ranking executive like the Co-President and COO can signal confidence in the company's future prospects, as they are converting options into actual shares.
- The exercise prices of $4.34 and $4.13 per share are below the implied market price at the time of exercise (as options are typically exercised when in-the-money), indicating a potential profit for the insider and suggesting the stock's value is perceived to be higher.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This insider transaction reflects an executive's personal investment decision within the medical technology or ophthalmology sector, where RxSight operates. Such transactions are common and are often viewed by the market as an indicator of management's belief in the company's value, irrespective of broader industry trends.
Related Party Transactions
- The reported transactions involve an executive (Ilya Goldshleger) of RxSight, Inc. exercising stock options to acquire company shares, which is a standard form of related party transaction in the context of executive compensation and insider ownership.
Stakeholder Impact
- Shareholders may view the Co-President and COO's increased direct ownership as a positive signal, potentially reinforcing confidence in the company's leadership and future prospects.
Key Dates
| Date | Description |
|---|---|
| 10/27/2020 | Date exercisable for a stock option grant. |
| 02/24/2021 | Date exercisable for a stock option grant. |
| 04/26/2021 | Date exercisable for a stock option grant. |
| 09/25/2025 | Transaction Date for option exercises and share acquisitions. |
| 09/26/2025 | Signature Date of the filing by Attorney-in-Fact. |
| 10/26/2026 | Expiration date for a stock option grant. |
| 03/13/2027 | Expiration date for a stock option grant. |
| 04/25/2027 | Expiration date for a stock option grant. |
Keywords
RxSight, RXST, insider transaction, stock options, Form 4, beneficial ownership, Ilya Goldshleger, Co-President, COO, equity, shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.